The latest biotech news

News and Trends 27 Jun 2016

CRISPR Therapeutics increases its Series B to a Massive €125M

Everyone wants to invest in CRISPR Therapeutics, it seems. The Basel and Cambridge, US biotech has raised more money for its ongoing Series B round, bringing the total to over €126M. The authorization for the first CRISPR trials have just arrived in the hands of the FDA, and this might have encouraged new investment. CRISPR Therapeutics […]

June 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 27 Jun 2016

Genticel is facing hard Times Again!

As presented last week, Genticel was getting back on track with the announcement of two major milestones with the aim to prepare the phase III. However, the major outcomes of its Phase II were expected to be presented on the 17th of June at Eurogin 2016 Congress… Here they are (and they are really bad)! GTL001 is […]

June 27, 2016 - 2 minutesmins - By Jerome Topsent

News and Trends 27 Jun 2016

“France has always been a Leader in Infectious Disease and Microbiology”

This is what Franck Lescure, a partner at VC firm Auriga Partners, told me when I met him in Paris at his office next to the Champs-Elysées. Their last fund, Auriga IV Bioseeds, focuses on infectious disease and microbiology, with 6 investments so far and 9 by the end of 2016. It was a great way to […]

June 27, 2016 - 4 minutesmins - By Philip Hemme

bioart julia lohmann maggots microbiome algae

News and Trends 25 Jun 2016

How to do art with 9000 Petri Dishes? Julia Lohmann’s BioArt

Julia Lohmann grew up in the German countryside, studied design in England and worked on a farm in Iceland. Now as a designer and researcher, she brings all these experiences to her work – with maggots, bacteria, algae and 9000 petri dishes. Julia Lohmann started with sculpture by collecting driftwood during her childhood in Hildesheim, in […]

June 25, 2016 - 2 minutesmins - By Denise Neves Gameiro

red algae global warming bioalbedo gfz potsdam

News and Trends 24 Jun 2016

Why would Snow-growing Algae be killing Glaciers?

Red Algae bloom on glaciers during summer, which may give the snow more than a nice pink shade. The darker color makes the glacier melt faster – a previously overlooked mechanism in climate change. In biotech, algae almost became synonymous with unlimited potential, including as a promising new generation of biofuels – so they should be pretty environment-friendly, right? […]

June 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 24 Jun 2016

#Brexit: Sad news for the UK Biotech scene…

The first thing I checked this morning was the outcome of the Brexit vote, and what sad news when I read Brexit won. It was close, but the only thing that matters is the end result. Now, what will be the impact of such a vote on the UK biotech scene? The result will be significant, […]

June 24, 2016 - 5 minutesmins - By Joachim Eeckhout

biotech of the week volitionrx belgium 1213x418

News and Trends 24 Jun 2016

Cost-effective diagnostics for cancer? Only with VolitionRx!

Aberdeen, we say goodbye to you! We’re leaving Scotland this week and are heading down to Belgium. Besides being the place where most of the European Union action happens, Belgium also has a strong and interesting biotech scene. That’s why in Namur we’re visiting VolitionRx, our Biotech of the Week. City: Namur (Belgium) Founded: 2010 Employees: 11-50 employees […]

June 24, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 23 Jun 2016

Alzheimer’s closer to a Vaccine with new Slovakian Phase II Trial

Axon Neuroscience is starting a Phase II trial with its immunotherapy for Alzheimer’s disease, which redirects the immune system against defective Tau proteins, thought to be the main cause of this major disease. Alzheimer’s disease is the cause of up to 70% of dementia cases, according to WHO, which translates in over 30 million patients […]

June 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

venomab recombinant antivenom laustsen refresh

News and Trends 23 Jun 2016

‘Snake-bite Jesus’ pitched at Labiotech Refresh

VenomAb made quite an impression at the Startup Battle of Labiotech Refresh. Want to know what makes a biotech audience gasp unanimously? Then take a look at VenomAb’s pitch… We had Andreas Laustsen, founder of VenomAb, pitch his startup’s mission to bring antivenoms out of the 1900s into the modern age of biotech. The idea really captured […]

June 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 23 Jun 2016

How did we grow from 0 to 40,000 Monthly Visitors in 18 Months?

The first 18 months of our startup have been a marathon for us, where each new visitor was like one more kilometer to conquer. Growing a digital media is not an easy task, especially if you want to build a good reputation based on the quality of your content. In this article, I share the […]

June 23, 2016 - 7 minutesmins - By Joachim Eeckhout

News and Trends 23 Jun 2016

Cellectis gets paid for a first Milestone, Investors are pleased

After successfully ‘saving’ two babies with terminal-stage acute Leukemia, Cellectis finally treated the first patient in its Phase I trial. A major milestone that could confirm the potential of its lead candidate UCART-19. It’s once again a success for the French biotech company! As it announced on Monday, the first patient has been treated in […]

June 23, 2016 - 2 minutesmins - By Jerome Topsent

News and Trends 22 Jun 2016

What is Microsoft doing with this French Precision Medicine Biotech?

Median Technologies is partnering up with software giant Microsoft to integrate big data into its oncology imaging systems – and deliver Precision Medicine from the cloud. Medical imaging is an important part of the rise of digital medicine. Cool projects in the field include the aortic graft simulation of EVARplanning (one of the startups at Italian incubator […]

June 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

CRISPR Therapeutics increases its Series B to a Massive €125M

Genticel is facing hard Times Again!

“France has always been a Leader in Infectious Disease and Microbiology”

How to do art with 9000 Petri Dishes? Julia Lohmann’s BioArt

Why would Snow-growing Algae be killing Glaciers?

#Brexit: Sad news for the UK Biotech scene…

Cost-effective diagnostics for cancer? Only with VolitionRx!

Alzheimer’s closer to a Vaccine with new Slovakian Phase II Trial

‘Snake-bite Jesus’ pitched at Labiotech Refresh

How did we grow from 0 to 40,000 Monthly Visitors in 18 Months?

Cellectis gets paid for a first Milestone, Investors are pleased

What is Microsoft doing with this French Precision Medicine Biotech?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!